BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 3021967)

  • 1. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a visually read ELISA for serodiagnosis and sero-epidemiological studies of kala-azar in the Baringo District, Kenya.
    Jahn A; Diesfeld HJ
    Trans R Soc Trop Med Hyg; 1983; 77(4):451-4. PubMed ID: 6636271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis and malaria prevalence in West Pokot District, Kenya.
    Mutero CM; Mutinga MJ; Ngindu AM; Kenya PR; Amimo FA
    East Afr Med J; 1992 Jan; 69(1):3-8. PubMed ID: 1628545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kala-azar control programme for remote tribal communities.
    Thakur CP; Frances Sister ; Therese Sister ; Victoria Sister ; Puspa Sister
    World Health Forum; 1994; 15(3):245-7. PubMed ID: 7945751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kala-azar in Varanasi (UP)--preliminary observations.
    Rai RN; Sehgal PN
    J Commun Dis; 1990 Jun; 22(2):120-3. PubMed ID: 2098410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicoepidemiological profile of kala azar patients in Delhi.
    Mittal V; Bhatia R; Sehgal S
    J Commun Dis; 1989 Dec; 21(4):255-61. PubMed ID: 2638373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
    Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kala-azar in Ballia district, Uttar Pradesh.
    Rao JS; Rahman SJ; Singh J; Singh SK
    J Commun Dis; 1992 Jun; 24(2):116-20. PubMed ID: 1344169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.